This page offers links to the Depression Guideline and supporting material intended for the diagnosis and management of adults with depression. Dates indicate when HealthTeamWorks posted the material or link.
Antidepressant citalopram (Celexa) may pose risk of abnormal heart rhythms
On March 28, 2012, the Food and Drug Administration issued a drug safety communication for the antidepressant citalopram (marketed as Celexa). The communication addresses maximum doses for selected patient subgroups and recommends against use in some patients.
Depression Guideline Materials
Depression Screening Tools
There are no fees associated with using the PHQ-9 but the MDQ must be purchased from Jones and Bartlett Publishers.
Patient Self-Care Materials
Treatment Considerations for Special Populations
Additional Materials for Providers